what glp 1 is serena williams using Tennis legend making headlines after her Super Bowl ad promoting GLP-1 weight-loss medication went viral. The retired star revealed she lost around 14 kg with Zepbound through telehealth company Are GLP-1s Performance-Enhancing Drugs? -

Evidence to support compensatory hyperphagia is limited

Underwriters are also getting better at detecting GLP-1 use through: Prescription databases Medical records requests Follow-up health questionnaires What This Means for Your Clients If currently on GLP-1 medications: Expect questions about medication use and duration Be prepared for potentially higher rates despite current health improvements Consider timing of application if they've been stable on medication for an extended period If recently stopped GLP-1 medications: Underwriters may view recent discontinuation as a risk factor Weight regain could further complicate the application process Medical follow-up showing sustained health improvements may help If planning to start GLP-1 medications: Understand that future applications may be affected by medication use Industry Trends to Watch Some forward-thinking insurance companies are exploring partnerships with GLP-1 providers to improve medication adherence

A gradual approach is more sustainable

As you can see, many types of individuals may turn to GLP-1 medications, and all of them must be aware of the risks to their oral health

One study indicated that TNF- can induce the expression of bone-related genes, including bone morphogenetic protein 2 (BMP-2), Msh homeobox 2 (Msx2), Wnt3a, and Wnt7a, and the upregulation of these genes is closely associated with increased aortic calcification [183]